GILD or VRTX: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
3 Spectacular High-Yield Dividend Stocks to Buy in November [Yahoo! Finance]
Gilead Sciences to Present at Upcoming Investor Engagements
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at Truist Financial Co. from $83.00 to $97.00. They now have a "hold" rating on the stock.